|
Search
Collections
Benchmarks
Upload document
Indication
CD55 Deficient Protein Losing Enteropathy
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 product
Product
Pozelimab
Clinical trial
An Open-Label, Expanded Access Program of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)
Status:
